A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. - Wikidata - wikimedia - TriplyDB

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

http://www.wikidata.org/entity/Q39909632

about

The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment The neurobiological link between OCD and ADHD Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders Evidence-based pharmacotherapy of obsessive-compulsive disorder.Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).Memantine: a review of possible uses in child and adolescent psychiatry Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial.Pharmacotherapy of anxiety disorders: a critical review Assessment and management of treatment-refractory obsessive-compulsive disorder in children.Glutamatergic agents for OCD and related disorders Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.THE USE OF GLUTAMATE MODULATING DRUGS IN OBSESSIVE COMPULSIVE DISORDER.Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders Effects of ketamine in treatment-refractory obsessive-compulsive disorder.Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.Management of obsessive-compulsive disorder comorbid with bipolar disorder.Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial.Glutamate and the Treatment of Obsessive-Compulsive Disorder Advances in pharmacotherapy for pediatric anxiety disorders.Pharmacological management of treatment-resistant obsessive-compulsive disorder.A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.Augmentation strategies in obsessive-compulsive disorder.Glutamate-based anxiolytic ligands in clinical trials.Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.Treatment of pediatric anxiety disorders.Emerging drugs to treat obsessive-compulsive disorder.Pharmacological treatment of obsessive-compulsive disorder The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review Obsessive-compulsive disorder: Insights from animal models.Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder.

P2860

Q24605193-69D18A0C-4C6C-41BF-8563-6E7268C0D980 Q24633004-1AD17FEA-38DA-41FB-965E-079CBF229B6B Q27002629-493EEA9C-052A-40BD-BDD8-4C0EDF9184D6 Q27009995-6F4A2E73-E069-4A08-9832-6686A2C8A193 Q34245428-7CAE4705-2567-4E72-BDBF-86D9E4AA4683 Q34296626-642C41A2-BFA6-4813-9E8A-6A3EC9292962 Q34335067-3E7838CA-FFE4-4C45-9098-6A77C53611A5 Q34344303-DD42DE01-E556-4C2A-B18E-8E05457599CE Q34653386-5D96B404-97DC-4A59-BF15-C38621A48EDC Q34678136-9C6EC727-5C18-49F6-8046-97A05D76FDB6 Q34761216-5EA7FD44-9267-460C-B448-E089D3C3FCB5 Q35686859-CEFC966E-8092-4740-BB9C-38A6F4ABDF9C Q35697831-32D24518-E96B-474B-BB91-0CC7BC3CC25B Q35967025-BC381D35-F72D-4915-A4B6-FCA4E27BA644 Q36029739-E05C810D-3FD2-4B3C-A19D-A1D067F75056 Q36647465-366AAFEA-3444-468C-A0D0-B89EA9BFAF23 Q36694513-536444D6-94CC-4507-84BA-AFCA276851CC Q36801195-F5ED8368-6005-4D5E-BF26-9B8DFD3C2069 Q36873932-EBBF9856-C35B-432C-9D37-B6517A57075A Q36887096-DD1E8138-20E7-4859-88C6-B6030989BECA Q36894271-174BF47F-2F92-4DCD-B48D-AE7A4BDC2F0E Q37055310-AA8892B8-7D26-459C-A4FA-915CE946B234 Q37099618-441729A4-C510-42BA-B911-FB34DC21A1CE Q37400532-A6021308-6C18-4FC3-9A72-E4C72A930CE5 Q37582283-036CF29E-D6BB-405F-BBD5-2D0C69CC4A25 Q37632753-3701A3AA-B309-4A09-B474-A135AB298432 Q37827822-522C6E82-C8E7-468E-9885-716221A62DD4 Q37893636-1AD4C968-E25D-4E95-B7E4-ED48789DD705 Q38004948-72CE5E8C-F2D1-4396-A599-D0040A35F509 Q38025454-4360ECC7-9B0C-46A8-954B-DF13AB03ED6D Q38057736-FC8D3BAD-EA0C-4734-BA52-32EDC9701179 Q38078029-FF32D159-7DF7-4C35-8F37-41F2A6C814FB Q38110306-2F9AD29B-9892-4B4E-91D5-7DC321EEB910 Q38154625-3B70F16C-6184-4502-9B29-0484C678E641 Q38166460-AABCCB51-CC11-48D0-B03A-9174D539C6B6 Q38174649-7CA78418-0742-48C9-85D6-13CE29A1CCE6 Q38242548-58D8CC8A-1066-436E-8DF7-ACE68713B058 Q38247298-7B5F3D2C-724B-4BEC-A88F-BAA7B85C263F Q38832138-5F131CD8-97A5-443E-A577-4B887F2EBC98 Q39189451-4267743C-2859-4B82-AD06-72064397014E

P2860

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

http://www.wikidata.org/entity/Q39909632

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@en

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@nl

type

label

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@en

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@nl

prefLabel

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@en

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@nl

P1433

Q39909632-073B2B46-8045-4BF5-B63F-9ADCEE9D4F44

P1476

Q39909632-D5787F9C-952C-4B5C-B230-9DEF8C14510A

P2093

Q39909632-4D400EC4-22B1-46F8-B23D-E4F16E1B8836

Q39909632-50FE3CFC-61CF-45B1-A48F-F41655AF5BDC

Q39909632-79D71C42-3A8A-4B3B-92F8-3A523250153F

Q39909632-A9801A05-BAF8-4897-8984-8C37F4DB2D83

Q39909632-A9E0044A-EEB6-42BA-88A1-94E2FA301752

Q39909632-C256819A-82E8-43B3-A376-4D6E0BC4B73C

Q39909632-E7F0D456-5279-4FA9-9956-3EACEDBEE788

P304

Q39909632-52782487-B666-43E0-85AE-BCF2A0CC1144

P31

Q39909632-F63F91A2-92AF-48F6-A50B-39002311938E

P356

Q39909632-BA8457B6-91AC-4D99-AD32-D20D40CE2A64

P407

Q39909632-61B0E90F-E222-4E6B-8E6F-5FEC22A8C9B8

P433

Q39909632-8F29D61A-0D7E-412B-BC61-500620B4F2A9

P478

Q39909632-964C1691-5E73-431C-A01F-C63129843269

P577

Q39909632-EF9591F4-E202-40DD-9E1F-5C94CF07ACC1

P698

Q39909632-521B81A4-7997-42F3-83D0-F0DE0D410479

P356

JCP.0B013E3181C856DE

P1433

Journal of Clinical Psychopharmacology

P1476

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

@en

P2093

Denise Egan Stack

http://www.w3.org/2001/XMLSchema#string

Dianne M Hezel

http://www.w3.org/2001/XMLSchema#string

Eric A Jenike

http://www.w3.org/2001/XMLSchema#string

Louis Shuster

http://www.w3.org/2001/XMLSchema#string

Michael A Jenike

http://www.w3.org/2001/XMLSchema#string

Nicholas H Dodman

http://www.w3.org/2001/XMLSchema#string

S Evelyn Stewart

http://www.w3.org/2001/XMLSchema#string

P304

34-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0B013E3181C856DE

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20075645

http://www.w3.org/2001/XMLSchema#string